跳至主要内容
临床试验/JPRN-jRCTs031180401
JPRN-jRCTs031180401进行中(未招募)2 期

A multicentre, single arm, confirmatory trial to evaluate the effectiveness of induction CDDP plus TS-1 with concurrent radiotherapy (66Gy) followed by surgical resection in patients with superior sulcus tumor.

Suzuki Kenji0 个研究点目标入组 60 人开始时间: 2019年3月20日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
Suzuki Kenji
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • (1) Histologically or cytologically proven non-small cell lung cancer, diagnosed using specimen material obtained from primary tumor or metastastatic lymph node
  • (2) Chest MRI or thoracic CT, direct invasion of the primary lesion to the organ of one of the following is suspected.
  • a) Invasion to the first rib or more superior chest wall
  • b) Subclavian vein or subclavian artery
  • (3) cN0, cN1
  • (4) Patients with evaluable lesions or measurable disease
  • (5) 20years or more, 75 years or less
  • (6) ECOG PS 0-1
  • (7) Expected FEV 1.0 > 800ml after lung resection , SpO2 (Room air) >95%
  • (8) Adequate organ function
  • (9) Written informed consent

排除标准

  • (1) Distant metastasis
  • (2) malignant pleural effusion, pericardial effusion, intrathoracic seeding.
  • (3) Uncontrollable systemic disease (hyper tension, diabetes mellitus etc.)
  • (4) Case with the administration of the flucytosine.
  • (5) Severe drug allergy
  • (6) Infection requiring intravenous administration of anti-viral agents antibiotics, or antifungals
  • (7) Hepatitis Bs antigen positive
  • (8) History of severe heart disease , Current or previous (within the last 1 year) history of myocardial infarction
  • (9) Traumatic fracture of unrecovery ,a high degree of wound
  • (10) Severe diarrhea
  • (11) Investigational new drug or the unapproved drug is administered
  • (12) Interstitial pneumonia or pulmonary fibrosis detectable on chest CT
  • (13) History of active double cancer
  • (14) History of pregnancy or lactation or Women suspected of being pregnant.Men who wish to make a child. or no intention to contraception
  • (15) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

研究者

发起方
Suzuki Kenji

相似试验

招募中
2 期
A multicentre,single arm,confirmatory trial to evaluate the effectiveness of induction CDDP plus TS-1 with concurrent radiotherapy(66Gy) followed by surgical resection in patients with superior sulcus tumor.Superior sulcus tumor
JPRN-UMIN000014386Advanced Clinical Trial chest surgery Group (ACTG)80
进行中(未招募)
不适用
Prospective, single-arm, multicenter trial to investigate the efficacy and safety of NT 201 (botulinum neurotoxin type A free of complexing proteins) and the duration of treatment effect after one injection session and in long-term treatment in patients with cervical dystoniaCervical dystonia, predominantly rotational spasmodic torticollisMedDRA version: 10.0Level: LLTClassification code 10064124Term: <Manually entered code. Term in E.1.1>
EUCTR2006-003410-18-DEMerz Pharmaceuticals GmbH
招募中
2 期
Remdesivir in treatment of COVID-19
IRCT20171122037571N2Tehran University of Medical Sciences120
招募中
1 期
Desensitisation with imlifidase prior to kidney transplant in highly sensitised childreHighly sensitised paediatric patients with a positive crossmatch against a living or deceased donor kidney.MedDRA version: 20.0Level: PTClassification code: 10023439Term: Kidney transplant rejection Class: 100000004870
CTIS2022-500230-28-00Hansa Biopharma AB8
招募中
3 期
A trial to evaluate the diagnostic performance of contrast-enhanced ultrasonography in pancreatic mass lesionsPatients with pancreatic mass lesions (pancreatic solid mass or pancreatic cystic mass)pancreatic mass, pancreatic ductal carcinoma, intraductal papillary mucinous neplasmD010190
JPRN-jRCT2051220085Kitano Masayuki301